Composition with effects of controlling oil, shrinking pores and soothing skin as well as preparation method and application of composition
By combining artemisia annua extract, red clover extract, senna extract and zinc PCA, this product addresses the issues of oil control, pore minimization and skin soothing in cosmetics, achieving a synergistic effect of multiple benefits and ensuring the stability of the cosmetic, making it suitable for oily and sensitive skin.
Patent Information
- Application Number
- CN202511076469.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-08-01
- Publication Date
- 2025-11-21
AI Technical Summary
Existing cosmetic products often offer only one function when dealing with oily and sensitive skin, failing to effectively control sebum secretion, minimize pores, or soothe skin inflammation. Furthermore, the application of zinc PCA in high-viscosity cosmetic formulations is limited, which can easily lead to viscosity instability.
By combining artemisia annua extract and its derivatives, red clover extract, senna extract and zinc PCA, this product achieves multiple benefits such as oil control, pore minimization and skin soothing by regulating sebaceous gland differentiation, inhibiting inflammatory factors and enhancing the integrity of the stratum corneum. At the same time, it improves the compatibility of zinc PCA in high-viscosity cosmetics.
It achieves significant oil control, pore minimizing, and skin soothing effects with low PCA zinc dosage, enhancing the stability and safety of cosmetics and making it suitable for sensitive skin.
Smart Images

Figure BDA0005529503310000051 
Figure BDA0005529503310000061 
Figure BDA0005529503310000071
Abstract
Description
Technical Field
[0001] This invention belongs to the field of cosmetic technology, and specifically relates to a composition that has the effects of oil control, pore minimizing and skin soothing, as well as its preparation method and application. Background Technology
[0002] The formation of oily and sensitive skin is a complex pathological process resulting from the combined effects of internal and external factors. Under the combined influence of exogenous factors (changes in environmental temperature, seasonal changes, mechanical friction, ultraviolet radiation, cosmetic irritation, and air pollutants) and endogenous factors (hormonal fluctuations during puberty, sleep rhythm disorders, mental stress, and emotional changes), sebaceous gland function becomes hyperactive, leading to abnormally increased sebum secretion. In this situation, consumers often over-rely on strong cleansing products or frequently exfoliate, coupled with improper care techniques (such as vigorous rubbing), ultimately resulting in damage to the skin barrier structure and a significant increase in transepidermal water loss (TEWL), forming a characteristic "oily on the outside, dry on the inside" pathological state. This state further activates the skin's immune system, triggering a cascade of inflammatory responses, while inflammatory mediators can in turn stimulate sebaceous gland proliferation and secretion, thus forming a vicious cycle that is difficult to break.
[0003] Currently, commercially available products generally suffer from a lack of specific efficacy: some products regulate sebum secretion by inhibiting sebaceous gland activity, but this has little effect on oily and sensitive skin; other products focus solely on anti-inflammatory and soothing effects, neglecting skin type differences (such as dry / oily), which may counterproductively exacerbate the imbalance of sebum secretion. Summary of the Invention
[0004] The present invention aims to solve at least one of the technical problems existing in the prior art. To this end, the present invention provides a composition that combines oil control, pore minimizing, and skin soothing effects, as well as its preparation method and application. This composition can simultaneously inhibit sebaceous gland cell differentiation, reduce sebum synthesis, and regulate secretion function, controlling excessive sebum secretion from the source. It can also significantly shrink pores visually by regulating keratinocyte metabolism and alleviate various discomforts caused by skin inflammation. Furthermore, this composition is gentle and non-irritating, suitable for sensitive and damaged skin, and especially suitable for people with oily and sensitive skin.
[0005] In a first aspect, the present invention provides a composition comprising, by weight percentage: 1% to 30% Artemisia annua extract and its derivatives, 1% to 40% Trifolium repens extract, 1% to 30% Scutellaria barbata extract and 0.1% to 40% zinc PCA.
[0006] Specifically, the mass percentage of the artemisia annua extract and its derivatives can be any point value or any two-point range between 1% and 30%, such as 1%, 5%, 10%, 15%, 20%, 25%, 30%, etc.
[0007] Specifically, the mass percentage of the red clover extract can be any point value or any two-point range between 1% and 40%, such as 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, etc.
[0008] Specifically, the mass percentage of the *Solanum lyratum* extract can be any point value or any two-point range between 1% and 30%, such as 1%, 5%, 10%, 15%, 20%, 25%, 30%, etc.
[0009] Specifically, the mass percentage of the PCA zinc can be any point value or any two-point range between 0.1% and 40%, such as 0.1%, 1%, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, etc.
[0010] In some embodiments of the present invention, the composition comprises the following components: 10%–30% Artemisia annua extract and its derivatives, 20%–40% red clover extract, 10%–30% senna extract and 10%–40% zinc PCA.
[0011] Specifically, the artemisia annua extract and its derivatives are compounds containing active ingredients obtained through chemical modification or biotechnology. They contain artemisinin, flavonoids, and other components that can regulate sebum secretion, reduce shine, inhibit inflammatory factors (such as IL-6 and TNF-α), and alleviate problems such as redness, sensitivity, and acne. They also have inhibitory effects on Propionibacterium acnes and Staphylococcus aureus, helping to improve seborrheic dermatitis.
[0012] Specifically, the red clover extract is rich in isoflavones, phenolic acids, polysaccharides, and antioxidants, which can effectively balance sebum secretion, shrink enlarged pores, and has antioxidant, skin-tone-evening, soothing, and anti-inflammatory effects.
[0013] Specifically, the extract of *Solanum nigrum* is rich in natural volatile essential oils, flavonoids, polyphenols and other compounds, which have the effects of regulating sebum, controlling oil and astringing, antibacterial and anti-inflammatory, and antioxidant, helping the skin to restore a healthy glow.
[0014] Specifically, the zinc PCA can inhibit 5α-reductase, reduce excessive sebum secretion, absorb excess oil, improve oily skin and large pores, and also has antibacterial, soothing and anti-inflammatory, and skin barrier repair functions.
[0015] By adopting the above technical solution, the main technical problems solved by the present invention are as follows:
[0016] 1. Comprehensive Management of Oily and Sensitive Skin: This invention combines red clover extract and senna extract to inhibit 5α-reductase activity, regulate sebaceous gland differentiation, and control oil production at its source. Artemisia annua extract and its derivatives can target and inhibit IL-6 / TNF-α, and when combined with red clover extract, they can block the NF-κB pathway, thereby effectively controlling inflammatory factors. Zinc PCA can enhance the integrity of the stratum corneum, maintain the skin's microecological balance, and repair the skin barrier.
[0017] 2. Multifunctional synergistic effect: This invention breaks through the limitations of single-ingredient efficacy by scientifically combining artemisia annua extract and its derivatives, red clover extract, senna extract and zinc PCA, achieving multiple synergistic effects of oil control, pore minimization, soothing and barrier repair.
[0018] 3. PCA Zinc Formulation Stability Issues: PCA zinc is a water-soluble zinc salt, and its ionic properties affect the viscosity of cosmetic formulations, especially in emulsions and creams where viscosity requirements are extremely high. Adding PCA zinc can lead to viscosity reduction or even system collapse, thus greatly limiting its application. This invention significantly improves its compatibility in high-viscosity systems such as emulsions / creams by rationally combining it with Artemisia annua extract and its derivatives, red clover extract, and senna extract, thereby expanding its application range.
[0019] 4. Low concentration and high efficiency: This invention achieves significant efficacy with low concentration of PCA zinc through the synergistic effect between components, such as the synergistic anti-inflammatory effect of artemisinin extract and its derivatives with red clover extract, and the synergistic oil control effect of PCA zinc with three other plant extracts. Compared with the traditional method of adding PCA zinc alone, which requires a higher dosage, the composition of this invention can achieve significant efficacy with low PCA zinc dosage, reducing irritation and meeting the needs of sensitive skin.
[0020] 5. Safety issues: This invention combines natural plant ingredients with zinc PCA to achieve both short-term rapid soothing and long-term skin conditioning effects while ensuring gentleness.
[0021] In some embodiments of the present invention, the artemisia extract and its derivatives include at least one of artemisia extract, artemisinin, artesunate, artemether liposomes, and fermented artemisia extract.
[0022] In some embodiments of the present invention, the red clover extract includes at least one of red clover extract (whole plant), red clover flower extract, and red clover leaf extract. Red clover extract (whole plant) refers to extracts from the entire red clover plant, without distinguishing between flowers, leaves, roots, or other parts.
[0023] In some embodiments of the present invention, the *Symplocos edulis* extract includes *Symplocos edulis* leaf extract and / or *Symplocos edulis* root extract.
[0024] A second aspect of the present invention provides a method for preparing the composition described in the first aspect of the present invention, comprising the following steps:
[0025] The components are mixed to obtain the composition.
[0026] A third aspect of the present invention provides a cosmetic product comprising the composition described in the first aspect of the present invention.
[0027] In some embodiments of the present invention, the composition accounts for 0.1% to 10% of the cosmetic by mass. The mass percentage can be any point value or any two points within the range of 0.1% to 10%, such as 0.1%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, etc.
[0028] In some embodiments of the present invention, the composition accounts for 0.5% to 2% of the cosmetic product by mass.
[0029] In some embodiments of the present invention, the cosmetic further includes at least one of a chelating agent, a thickener, a moisturizer, an emulsifier, a preservative, and a skin protectant.
[0030] In some embodiments of the present invention, the chelating agent includes at least one of disodium EDTA, tetrasodium EDTA, and HEDTA.
[0031] In some embodiments of the present invention, the thickener includes at least one selected from ammonium acryloyldimethyl taurate / VP copolymer, acrylate / C10-30 alkanol acrylate crosspolymer, carbomer, hydroxyethyl acrylate / sodium acryloyldimethyl taurate copolymer, cetearyl alcohol, and stearic acid.
[0032] In some embodiments of the present invention, the emollient includes at least one selected from shea butter, jojoba seed oil, squalane, meadowfoam seed oil, polydimethylsiloxane, olive fruit oil, and sea buckthorn fruit oil.
[0033] In some embodiments of the present invention, the emulsifier includes at least one selected from glyceryl stearate, PEG-100 stearate, cetearyl glucoside, cetearyl alcohol, sodium stearoyl glutamate, sodium methylstearoyl taurate, and polyglycerol emulsifiers.
[0034] In some embodiments of the present invention, the preservative includes at least one selected from phenoxyethanol, methylparaben, propylparaben, and sodium benzoate.
[0035] In some embodiments of the present invention, the skin protectant includes at least one of sodium hyaluronate, panthenol, ceramide NP, and peptides.
[0036] In some embodiments of the present invention, the types of cosmetics include toners, serums, lotions, creams, masks, gels, cleansers, or base makeup.
[0037] Compared with the prior art, the beneficial effects of the present invention are as follows:
[0038] (1) By rationally combining PCA zinc, artemisia annua extract and its derivatives, red clover extract and senna extract, the present invention can expand the amount and scope of PCA zinc use. That is, when the amount of PCA zinc is similar, adding the composition of the present invention to some cosmetic formulations with high viscosity requirements is more stable and has a wider range of applications than adding PCA zinc alone, so that PCA zinc can play a better role.
[0039] (2) The composition of the present invention contains Artemisia annua extract and its derivatives, red clover extract, senna extract and zinc PCA. This unique combination of formulations creates a good synergistic effect between the components, thereby significantly improving the effects of oil control, soothing and shrinking pores, and also relieving redness and enhancing the skin barrier.
[0040] (3) The composition provided by the present invention is mild and non-irritating, with strong universality, and is suitable for different skin groups, such as people with fragile and easily damaged skin. Detailed Implementation
[0041] The present invention will be further described in detail below through specific embodiments. Unless otherwise specified, the raw materials, reagents, or apparatus used in the embodiments can be obtained from conventional commercial sources or by existing technical methods. Unless otherwise specified, the experimental or testing methods are conventional methods in the art.
[0042] Examples 1-6 and Comparative Examples 1-18 each provide a composition, the specific formulation of which is shown in Table 1 by weight percentage.
[0043] Table 1 Composition Formulation
[0044]
[0045]
[0046]
[0047] The compositions of Examples 1-6 and Comparative Examples 1-18 described above can be prepared by uniformly mixing the components.
[0048] Application Example 1
[0049] The composition of Example 1 was used to prepare a moisturizing cream, and the specific formulation is shown in Table 2.
[0050] Table 2. Moisturizing Cream Formulas
[0051]
[0052] The preparation method of the moisturizing cream according to Example 1 includes the following steps:
[0053] (1) Add the A phase raw material to the emulsifying pot in sequence, heat to 80°C, and stir evenly;
[0054] (2) Add the B phase raw material to the oil phase pot in sequence, heat to 80°C, and stir to disperse evenly;
[0055] (3) Before emulsification, add the C phase raw material to the oil phase pot, stir and disperse evenly, then transfer the raw material in the oil phase pot into the emulsification pot, homogenize and emulsify for 10 minutes, and start cooling after the homogenization is complete.
[0056] (4) When the temperature drops to 60°C, add the D-phase raw material and the E-phase raw material into the emulsifying pot, stir evenly and continue to cool down;
[0057] (5) When the temperature drops to 45°C, add the F phase raw material to the emulsification pot, stir and disperse evenly, and then cool down to below 37°C to obtain the moisturizing cream.
[0058] Application Examples 2-6
[0059] Compared with Application Example 1, in Application Examples 2 to 6, the composition of Example 1 was replaced with the composition of Example 2 to 6, and other conditions were the same as in Application Example 1.
[0060] Application Comparative Examples 1-18
[0061] Compared with Application Example 1, in Application Comparative Examples 1 to 18, the composition of Example 1 was replaced with the composition of Comparative Examples 1 to 18, and other conditions were the same as in Application Example 1.
[0062] Product performance testing
[0063] Test Example 1: Product Stability Test
[0064] The moisturizing creams from Application Examples 1-6 and Comparative Examples 1-18 were used as test samples. The heat resistance and cold resistance of the samples were tested using the high and low temperature test method according to QB / T1857. The cold resistance temperatures were (-15±2)℃ and (-8±2)℃, the heat resistance temperatures were (48±1)℃ and (40±1)℃, and the room temperature was (25±2)℃. The stability of the products was observed at 24h, 3 days, 7 days, 14 days, 28 days, 45 days, 60 days, 90 days, 120 days, and 160 days. The specific stability test results are shown in Table 3 below.
[0065] Table 3. Results of sample stability tests at different temperatures
[0066]
[0067]
[0068]
[0069]
[0070] Table 3 shows that the moisturizing creams from Application Examples 1-6, Comparative Examples 4, 7, 9, 10, and 12-14 remained relatively stable for 160 days under both high and low temperatures. Comparative Examples 5-6, 8, and 11 showed lower viscosity than normal creams at room temperature. Comparative Examples 1-3, 5-6, 8, and 11 exhibited varying degrees of coarsening and layering at different times under high temperatures. This may be attributed to the varying degrees of reduction in viscosity due to the ionic properties of zinc PCA, leading to coarsening and layering at high temperatures. Comparative Examples 15-18 showed varying degrees of discoloration at high temperatures, possibly due to the added oil-controlling ingredient niacinamide. In conclusion, this invention combines artemisia annua extract, red clover extract, senna extract, and zinc PCA, resulting in a more stable formulation and reducing the impact of zinc PCA ionic properties on the formulation.
[0071] Test Example 2: Skin Irritation Test
[0072] Two hundred and forty healthy volunteers aged 20–50 years (male and female) were selected and divided into 24 groups of 10 each. The compositions of Examples 1–6 and Comparative Examples 1–18 were used in each group. 0.03 mL of the test sample was placed in the drug chamber of the patch test tape. Immediately afterward, the patch test tape containing the sample was applied longitudinally from the bottom to the normal skin of the subject's left forearm. The drug chambers were gently pressed to expel air and ensure even distribution of the test substance. The test sites were marked for observation. The patch tape was removed after 24 hours, and skin condition was observed at 0.5 hours, 24 hours, and 48 hours. Skin reactions were recorded and analyzed according to the CTFA guidelines. The blank control group underwent the same test on the right upper arm of the volunteers using deionized water.
[0073] The criteria for skin irritation testing are shown in Table 4; the test results are shown in Table 5.
[0074] Table 4. Identification Criteria for Skin Irritation Tests
[0075] grade symbol Identification Standards 0 - Negative reaction; no irritation, no erythema 1 ± Intentional reaction: Mild erythema 2 + Weak positive reaction: erythema 3 ++ Strong positive reaction: erythema, papules, vesicles 4 +++ Extremely strong positive reaction: severe edema, large bullae
[0076] Table 5 Results of Skin Irritation Tests
[0077]
[0078]
[0079]
[0080]
[0081] As shown in Table 5, no adverse reactions were observed in volunteers using Examples 1-6, Comparative Examples 1-14, and Comparative Example 18, indicating that the compositions are mild and non-irritating, and have good safety. However, volunteers using the compositions of Comparative Examples 15-17 experienced varying degrees of skin reactions, suggesting that a certain component in the composition, when combined with niacinamide, may cause mild skin irritation.
[0082] Experiment 3: Skin Oil Control Test
[0083] Two hundred and forty volunteers aged 20–50 (male and female) with oily or combination skin were selected and divided into 24 groups of 10 each. Each group used one of the moisturizing creams from Examples 1–6 and the other from Comparative Examples 1–18. The creams were used twice daily for a 28-day repeated use trial, with results obtained on days 0, 14, and 28. The Tape method was used to test sebum on the forehead. The test results at 14 days and 28 days were compared with the test results at 0 days, and the comparison results are shown in Tables 6 and 7.
[0084] Table 6. Sebum test results after 14 days (person)
[0085]
[0086]
[0087] Table 7. Sebum test results after 28 days (person)
[0088]
[0089]
[0090] As shown in Tables 6 and 7, volunteers using the samples from Application Examples 1-6 experienced a reduction in sebum production of over 10% after 14 days. The oil-controlling effect became more pronounced with increasing usage days, reaching 30%-50% after 28 days. In contrast, samples from Comparative Examples 1-14, whose compositions consisted of one (two or three) of Artemisia annua extract, red clover extract, senna extract, and zinc PCA, did not exhibit the same oil-controlling effect as the Application Examples. Comparative Examples 15-18 showed the oil-controlling effects after replacing one component of the composition with niacinamide. While the addition of niacinamide improved the oil-controlling effect, it was still significantly different from the Application Examples. Therefore, this invention, by combining Artemisia annua extract, red clover extract, senna extract, and zinc PCA, demonstrates a synergistic effect in oil control, effectively reducing sebum secretion.
[0091] Experiment 4: Test on the effect of reducing pore diameter and volume
[0092] Two hundred and forty volunteers aged 20–50 (male and female) with oily or combination skin were selected and divided into 24 groups of 10 each. Each group used one of the moisturizing creams from Examples 1–6 and the other from Comparative Examples 1–18. The creams were applied twice daily for a 28-day repeated use trial. Visible pores (>0.25 mm) around the cheeks and nose were measured using an image analysis device at days 0 and 28. The results of the reduction in pore diameter and volume after 28 days of use were compared with those after day 0. The results are shown in Table 8.
[0093] Table 8. Test results of pore diameter and volume reduction after 28 days of use (person)
[0094]
[0095]
[0096]
[0097] As shown in Table 8, compared with Comparative Examples 1-18, after 28 days of using the samples from Application Examples 1-6, a greater number of people experienced a reduction in pore diameter and volume ranging from 20%-30% and 30%-40%, respectively. This indicates that the samples from the Application Examples resulted in a greater reduction in pore size. The reason for this may be that while red clover extract and *Trifolium repens* extract have some pore-shrinking effects, *Artemisia annua* extract has better anti-inflammatory effects, which can alleviate enlarged pores caused by inflammatory factors to a certain extent. Furthermore, the addition of zinc PCA can reduce oil buildup and pore blockage, thus making pores appear finer. Therefore, this invention, by adding the compounded *Artemisia annua* extract, red clover extract, *Trifolium repens* extract, and zinc PCA to the moisturizing cream, has a synergistic effect and a better pore-shrinking effect.
[0098] Experiment 5: Soothing Efficacy Test
[0099] Two hundred and forty participants aged 20–50 years (male and female) with sensitive skin were selected and divided into 24 groups of 10 each. A randomized half-face test was conducted, with samples applied twice daily. On days 0 (D0), 7 (D7), and 14 (D14), after cleansing their faces, participants maintained the area at a temperature of 20±2℃ and humidity of 50±10% for 20 minutes before completing a lactic acid tingling test questionnaire. The questionnaire used a 4-point scale: 0 for no sensation, 1 for mild sensation, 2 for moderate sensation, and 3 for severe sensation. Intermediate scores such as 0.2, 1.2, 2.2, or other intermediate values could be used to describe the degree of sensation. The results are shown in Table 9.
[0100] Table 9. Average lactic acid stinging score
[0101]
[0102]
[0103] As shown in Table 9, Artemisia annua extract has a good effect on relieving stinging in the short term (D7), and its effect on relieving stinging in the long term (D14) is slightly better than that in the short term (D7), but the effect is not significant. With the addition of red clover extract, senna extract, and zinc PCA, although the effect on relieving stinging in the short term (D7) is similar to that of Artemisia annua extract alone, the effect on relieving stinging in the long term (D14) is more obvious and significant. This may be related to their regulation of sebaceous gland cell differentiation, promotion of keratinocyte differentiation, and epidermal barrier repair. Therefore, the composition of this invention has significant soothing effects in both the short and long term.
[0104] The preferred embodiments of the present invention have been described in detail above, but the present invention is not limited to the embodiments described. Those skilled in the art can make various equivalent modifications or substitutions without departing from the spirit of the present invention, and these equivalent modifications or substitutions are all included within the scope defined by the claims of this application.
Claims
1. A composition, characterized in that, The composition comprises, by weight percentage, the following components: 1%–30% Artemisia annua extract and its derivatives, 1%–40% red clover extract, 1%–30% senna extract and 0.1%–40% zinc PCA.
2. The composition according to claim 1, characterized in that, The composition comprises, by weight percentage, the following components: 10%–30% Artemisia annua extract and its derivatives, 20%–40% red clover extract, 10%–30% senna extract and 10%–40% zinc PCA.
3. The composition according to claim 1 or 2, characterized in that, The Artemisia annua extract and its derivatives include at least one of Artemisia annua extract, artemisinin, artesunate, artemether liposomes, and fermented Artemisia annua extract.
4. The composition according to claim 1 or 2, characterized in that, The red clover extract includes at least one of red clover extract (whole plant), red clover flower extract, and red clover leaf extract.
5. The composition according to claim 1 or 2, characterized in that, The *Symplocos edulis* extract includes *Symplocos edulis* leaf extract and / or *Symplocos edulis* root extract.
6. A method for preparing the composition according to any one of claims 1-5, characterized in that, Includes the following steps: The components are mixed to obtain the composition.
7. A cosmetic product, characterized in that, The cosmetic product includes the composition according to any one of claims 1-5.
8. The cosmetic product according to claim 7, characterized in that, The composition constitutes 0.1% to 10% of the cosmetic product by mass.
9. The cosmetic product according to claim 7, characterized in that, The cosmetics also include at least one of the following: chelating agents, thickeners, emollients, emulsifiers, preservatives, and skin protectants.
10. The cosmetic product according to claim 7, characterized in that, The types of cosmetics include toners, serums, lotions, creams, masks, gels, cleansers, or base makeup.
